Foidart J ‐M., Munaut C, Chantraine F, Akolekar R, Nicolaides KH. Maternal plasma soluble endoglin at 11–13 weeks’ gestation in pre‐eclampsia. Ultrasound in Obstetrics & Gynecology. 2010;35(6):680–7.
2.
Poon LCY, Karagiannis G, Leal A, Romero XC, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks. Ultrasound in Obstetrics & Gynecology. 2009;34(5):497–502.
3.
Scazzocchio E, Figueras F. Contemporary prediction of preeclampsia. Current Opinion in Obstetrics & Gynecology. 2011;23(2):65–71.
4.
Poon LCY, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks. Prenatal Diagnosis. 2010;30(3):216–23.
5.
Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol. 2001;(6):477–84.
6.
Mukhopadhyay A, Sharma P, Dasgupta S, Dasgupta S, Sharma P, Ghosh T. Prediction of pre-eclampsia: comparative analysis of two screening tests. J Indian Med Assoc. 2012;(8):546–7.
7.
Kang A, Struben H. Präeklampsie-Screening im 1. und 2. Trimenon. Therapeutische Umschau. 2008;65(11):663–6.
8.
Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioğlu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine. 2010;23(8):880–6.
9.
Guven MA, Coskun A, Ertas IE, Aral M, Zencırcı B, Oksuz H. Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight. Hypertension in Pregnancy. 2009;28(2):190–200.
10.
Bahado-Singh R, Jodicke C. Uterine artery Doppler in first-trimester pregnancy screening. Clin Obstet Gynecol. 2010;(4):879–87.
11.
Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GHA, Schielen PCJI. Evaluation of 7 Serum Biomarkers and Uterine Artery Doppler Ultrasound for First-Trimester Prediction of Preeclampsia: A Systematic Review. Obstetrical & Gynecological Survey. 2011;66(4):225–39.
12.
Baumann M, Bersinger N, Surbek D. Serum markers for predicting pre-eclampsia. Mol Aspects Med. 2007;(2):227–44.
13.
Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Brumatti LV, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta. 2012;33(6):495–501.
14.
Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. American Journal of Obstetrics and Gynecology. 2010;203(4):383.e1-383.e8.
15.
Onwudiwe N, Yu CKH, Poon LCY, Spiliopoulos I, Nicolaides KH. Prediction of pre‐eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound in Obstetrics & Gynecology. 2008;32(7):877–83.
16.
Papageorghiou A, Campbell S. First trimester screening for preeclampsia. Curr Opin Obstet Gynecol. 2006;(6):594–600.
17.
Spencer K, Cowans N, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;(2):128–34.
18.
Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First trimester maternal serum placental protein 13 for the prediction of pre‐eclampsia in women with a priori high risk. Prenatal Diagnosis. 2009;29(8):781–9.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
